Laerdal Million Lives Fund is a venture capital firm dedicated to investing in early-stage companies that offer commercial-ready healthcare technologies. The firm emphasizes life-saving solutions that can significantly reduce mortality rates in critical areas such as maternal and neonatal health, emergency medicine, critical care, and surgery. By supporting innovations that enhance medical education and training for healthcare providers and patients, Laerdal Million Lives Fund aims to fulfill its overarching mission of saving one million lives annually by 2030. Headquartered in San Francisco, California, with an additional office in Stavanger, Norway, the firm typically makes initial investments ranging from $1 million to $5 million.
CorFlow Therapeutics is a medtech startup focused on developing innovative technologies for the diagnosis and treatment of microvascular obstructions (MVO) in patients experiencing severe heart attacks. The company has created a controlled flow infusion system that measures the degree of MVO through a proprietary concept known as dynamic microvascular resistance. This system provides interventional cardiologists with critical data that can be compared to post-procedure contrast-enhanced magnetic resonance imaging. By enabling accurate diagnosis and treatment of MVO, CorFlow aims to reduce both short- and long-term complications in heart attack patients, addressing significant unmet medical needs in cardiovascular care.
Boulder Care
Venture Round in 2024
Boulder Care, Inc. is a telemedicine-based platform focused on treating opioid addiction through a combination of medication and peer support. Founded in 2017 and located in Portland, Oregon, the company provides comprehensive services that include patient support, medication management, and psychosocial services. By leveraging digital health technology, Boulder Care aims to improve access to effective treatment for individuals struggling with opioid use, enhancing the experience for both patients and their care teams. The organization serves a diverse clientele, including patients, providers, and various health organizations, contributing to the advancement of the behavioral health industry.
Ciconia Medical
Pre Seed Round in 2024
Ciconia Medical focuses on maternal health by developing innovative medical devices aimed at reducing invasiveness, pain, and risk during childbirth. The company's key product is an AI-based vaginal examination tool that enables clinicians to make informed labor decisions based on precise and independent measurements. This approach enhances safety and comfort for both mothers and their newborns, fostering a gentler childbirth experience.
Avive
Venture Round in 2024
Avive Solutions is a company that develops an advanced Automated External Defibrillator (AED) aimed at improving survival rates from sudden cardiac arrest (SCA). Their device is designed to be portable, affordable, and user-friendly, ensuring that anyone can effectively respond to an SCA incident. In addition to the AED, Avive offers a connected software platform that facilitates the transfer of critical incident data to emergency services and healthcare professionals, enhancing the overall response to cardiac emergencies. By addressing the challenges associated with SCA, Avive Solutions aims to empower individuals and organizations to save lives more effectively. The company is based in Brisbane, California.
AMOpportunities
Series A in 2023
AMOpportunities, Inc. is a company based in Chicago, Illinois, that specializes in providing short-term training programs for international medical students and graduates. Founded in 2013, it connects these individuals with U.S. physicians and medical institutions to facilitate clinical rotations across more than 200 clinical sites in over 70 medical specialties and subspecialties. The platform not only offers opportunities for clinical experiences but also provides essential support services, including visa and housing assistance. By enabling international medical trainees to engage with U.S. healthcare professionals, AMOpportunities enhances their educational journey and practical knowledge in the medical field.
Cardiosense
Series A in 2022
Cardiosense develops a physiological waveform AI platform aimed at creating predictive biomarkers for the detection and treatment of cardiac diseases. The company utilizes raw biosignals and advanced signal processing techniques to gain insights into cardiac functions and identify pre-symptomatic markers of cardiac conditions. By leveraging multi-sensor devices and proprietary algorithms, Cardiosense focuses on non-invasive monitoring solutions that enhance healthcare professionals' ability to analyze cardiac health data and track patient well-being. This innovative approach facilitates early detection of diseases, ultimately aiming to improve patient outcomes in cardiac care.
Boulder Care
Series B in 2022
Boulder Care, Inc. is a telemedicine-based platform focused on treating opioid addiction through a combination of medication and peer support. Founded in 2017 and located in Portland, Oregon, the company provides comprehensive services that include patient support, medication management, and psychosocial services. By leveraging digital health technology, Boulder Care aims to improve access to effective treatment for individuals struggling with opioid use, enhancing the experience for both patients and their care teams. The organization serves a diverse clientele, including patients, providers, and various health organizations, contributing to the advancement of the behavioral health industry.
Avive
Series A in 2022
Avive Solutions is a company that develops an advanced Automated External Defibrillator (AED) aimed at improving survival rates from sudden cardiac arrest (SCA). Their device is designed to be portable, affordable, and user-friendly, ensuring that anyone can effectively respond to an SCA incident. In addition to the AED, Avive offers a connected software platform that facilitates the transfer of critical incident data to emergency services and healthcare professionals, enhancing the overall response to cardiac emergencies. By addressing the challenges associated with SCA, Avive Solutions aims to empower individuals and organizations to save lives more effectively. The company is based in Brisbane, California.
RelianceHMO
Series B in 2022
Kangpe Nigeria Limited operates a telemedicine platform that connects patients with doctors for online health consultations. Founded in 2015 and based in Lagos, Nigeria, the company offers subscription-based services allowing patients to ask health-related questions and receive medical advice. Doctors on the platform provide guidance on symptoms, disease diagnosis, and treatment based on detailed descriptions of patients' health conditions. Kangpe aims to make health services more accessible and affordable by leveraging technology, ensuring that patients can articulate their medical history and current issues to facilitate accurate diagnoses and effective treatment recommendations.
Reliance Health
Series B in 2022
Reliance Health is a healthcare technology company focused on improving the affordability and accessibility of healthcare in emerging markets. The company employs an integrated approach that combines affordable health insurance with telemedicine services and a network of both partner and proprietary healthcare facilities. This model aims to provide comprehensive care for individuals, families, and organizations, effectively addressing their health concerns through managed care solutions.
Tele911
Venture Round in 2021
Tele911 is a technology company focused on enhancing emergency medical services through its Tele911 Virtual Visit platform. This patient-centered emergency care solution integrates telemedicine and patient navigation to address the needs of stable patients, offering alternatives to unnecessary ambulance transports to hospital emergency rooms. By enabling emergency medical service providers to consult with patients remotely, Tele911 aims to improve patient care while simultaneously reducing costs within the healthcare system.
Aloe Care Health
Seed Round in 2021
Aloe Care Health, Inc. is a company focused on enhancing in-home elder care through its innovative voice-activated digital care assistant. Founded in 2013 and based in New York, Aloe Care Health provides a comprehensive solution that includes a Smart HUB and smart sensors designed to monitor falls, motion, air quality, and temperature. This technology allows professional caregivers and families to stay connected and collaboratively manage care for older adults. With features such as 24/7 access to an emergency call center and real-time alerts, Aloe Care aims to improve safety and well-being for seniors, making it easier for loved ones to organize and track all aspects of their care.
MobileODT
Series C in 2020
MobileODT Ltd develops optical diagnostic devices and software services aimed at early cancer detection. The company offers the EVA COLPO, a portable and FDA-cleared colposcope that connects to the internet, making it easy for healthcare providers to conduct examinations. The EVA SANE system allows for the secure management of patient data, including photos and notes, on a HIPAA-compliant server. Additionally, the EVA WELL tool enhances gynecologic exams through digital visualization. MobileODT also provides a mobile application for remote image capture and patient information tracking, alongside a cloud-based portal for collaboration and reporting. Other products include Eviscope, designed for documenting violence and abuse, EviDx for case documentation, and EviCenter for managing patient data. Founded in 2012 and headquartered in Tel Aviv, Israel, with an office in New York, MobileODT has established a strong presence in markets such as the U.S., Africa, and India, having conducted over 40,000 procedures across 29 countries.
RapidSOS
Series C in 2020
RapidSOS, Inc. is an emergency response data platform that connects life-saving information from over 350 million devices directly to 9-1-1 and first responders during emergencies. Founded in 2012 and based in New York, the company offers a range of solutions including Clearinghouse, which enables users to send emergency requests from RapidSOS-enabled devices, and an Emergency API suite that delivers user data to emergency services. Additionally, the RapidSOS Portal provides public safety agencies with secure access to essential Next Generation 911 (NG911) data. The platform supports more than 4,800 Emergency Communications Centers and plays a vital role in protecting over 90% of the U.S. population, responding to approximately 250 million emergencies annually. By collaborating with certified partners, RapidSOS enhances response capabilities by transmitting critical data such as precise location and real-time health information, ultimately aiming to improve emergency response efficiency and save lives.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.